Fig. 4From: Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapyIllustration of aerosol dose (percentage) for each delivery modality with concurrent HFNT, during simulated healthy adult breathing. The values represented are mean ± standard deviation (expressed in percentage) of three independent experimentsBack to article page